Quoin Pharmaceuticals releases second episode of ‘Living with Netherton’ series

Quoin Pharmaceuticals (QNRX) announced the release of the second episode in its “Living with Netherton” video series, part of the company’s broader NETHERTON NOW awareness campaign. This installment features Norma Coles, a 79-year-old woman whose diagnosis with Netherton Syndrome came decades after she was first evaluated by the condition’s namesake, Dr. Edward Netherton. “Norma’s story reminds us why our work is critically important,” said Dr. Michael Myers, Co-Founder and Chief Executive Officer of Quoin Pharmaceuticals. “At a time when there are still no FDA-approved treatments for Netherton Syndrome, her experience illustrates both the long road so many patients have traveled and the urgency of delivering a transformative treatment option. Our ongoing clinical trials of QRX003 have generated encouraging initial data, including meaningful improvements in skin healing, clear reductions in painful inflammation and pruritus while leading to a much enhanced quality of life. We remain deeply committed to completing the development of what we hope will become the first approved treatment for this devastating disease. Stories like Norma’s fuel our determination every step of the way.”